What are the adverse reactions of Lenvatinib? How do patients cope with and manage these reactions?

Lenvatinib (Lenvatinib) is an oral multi-target tyrosine kinase inhibitor (TKI), mainly used to treat a variety of solid tumors such as thyroid cancer, hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Although this drug has good efficacy in anti-tumor treatment, it may also cause a series of adverse reactions. Reasonable management of these side effects can help patients improve tolerance and successfully complete treatment.

1. Common adverse reactions of lenvatinib

1.Hypertension: Lenvatinib often causes an increase in blood pressure, especially during the first few weeks of treatment. Hypertension may increase the risk of cardiovascular events and therefore requires close monitoring.

2.Proteinuria: Some patients may experience an increase in urinary protein during treatment, and severe cases may develop nephrotic syndrome.

3.Digestive system discomfort: including diarrhea, nausea, vomiting, loss of appetite, stomatitis, etc., which may lead to weight loss and malnutrition.

4.Fatigue and weakness: Many patients will feel tired while taking the medicine, which affects their daily life.

5.Hand-foot syndrome: manifests as skin pain, redness, peeling and even ulceration on the palms and soles of the feet, affecting walking and hand activities.

6.Abnormal liver function: Some patients may experience elevated liver enzymes, which may lead to liver damage in severe cases.

7.Bleeding risk: Lenvatinib can inhibit angiogenesis, leading to nosebleeds, gum bleeding, and even gastrointestinal bleeding.

8. Thyroid dysfunction: Some patients may develop hypothyroidism (hypothyroidism), which affects metabolism and energy levels.

2. Management and response strategies for side effects

1. Hypertension management

Regular monitoring: It is recommended that patients measure baseline blood pressure before treatment and self-measure blood pressure daily during medication.

Adjust your lifestyle: Reduce salt intake, avoid caffeine and alcohol, and maintain moderate exercise to help control blood pressure.

Medical control: For patients with more severe hypertension, doctors may prescribe antihypertensive drugs, such as calcium channel blockers (such as amlodipine) or beta blockers. In uncontrolled conditions, lenvatinib dose adjustment may be necessary.

2.Proteinuria Management

Monitor urine protein: It is recommended to conduct regular urine tests during treatment. If proteinuria continues to increase, the dose should be reduced or the medication should be suspended.

Protect kidney function: Avoid nephrotoxic drugs (such as nonsteroidal anti-inflammatory drugs) and maintain adequate fluid intake.

3. Relief of digestive system discomfort

Diet adjustment: Avoid greasy, spicy and overly sweet foods, and choose foods that are easy to digest, such as rice porridge, lean meat soup, etc.

Antidiarrheal treatment: For those with mild diarrhea, electrolytes can be replenished through dietary adjustments. In severe cases, antidiarrheal drugs (such as loperamide) can be used.

Oral care: If stomatitis occurs, rinse your mouth with saline or soda water to keep your mouth clean and avoid spicy food.

4. Management of fatigue and fatigue

Take adequate rest: arrange your work and rest reasonably to avoid overexertion.

Nutritional supplements: Eat a balanced diet and take in more protein, vitaminsB family, etc. to help maintain energy levels.

Mild exercise: Appropriately engage in low-intensity exercise such as walking and yoga to improve body tolerance.

5. Management of hand-foot syndrome

Preventive care: Keep skin moisturized, use mild hand creams and emollients, and avoid prolonged rubbing of hands and feet.

Treatment measures: For mild symptoms, urea cream or vitamin E cream can be applied. In severe cases, the dose of lenvatinib may need to be adjusted.

6. Management of abnormal liver function

Regular monitoring: It is recommended that patients check liver function every 2-4 weeks, such as ALT, AST, bilirubin, etc.

Reduce burden on the liver: avoid alcohol intake, eat less high-fat foods, and try to avoid other drugs that may cause liver damage.

7. Prevent the risk of bleeding

Avoid anticoagulants: If you need to take anticoagulants such as aspirin and warfarin, you should consult your doctor first.

Oral care: Use a soft-bristled toothbrush to avoid gum damage and reduce the risk of bleeding.

Close observation: If bleeding symptoms such as melena or vomiting blood occur, seek medical attention immediately.

8. Management of thyroid dysfunction

Regular testing: It is recommended that patients check thyroid function (TSH, T3, T4) every 2-3 months.

Hypothyroidism treatment: If hypothyroidism is diagnosed, the doctor may recommend taking levothyroxine sodium (Euthyroxine) to supplement the hormone.

Lenvatinib, as a highly efficient anti-tumor targeted drug, has shown significant efficacy in the treatment of various malignant tumors, but it may also cause a variety of side effects. Reasonable management of adverse reactions, close monitoring of physical changes, and adoption of targeted prevention and treatment measures can effectively improve the patient's tolerance and ensure the smooth progress of treatment. If patients experience serious side effects during medication, they should communicate with their doctor in a timely manner to adjust the dosage or adopt other treatment options to balance efficacy and safety.

Reference materials:https://www.lenvima.com/